Eterna Therapeutics's total assets for Q2 2025 were $7.58M, an increase of 49.91% from the previous quarter. ERNA total liabilities were $3.14M for the fiscal quarter, a -71.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.